임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· Primary Immune Thrombocytopenia (ITP)코르티코스테로이드 치료 실패 소아 원발성 면역혈소판감소증 환자에서 엘트롬보팍에 추가한 이아날루맙 연구
A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
리드: 노바티스
- 2상모집 예정· PIK3CA-Related Overgrowth Spectrum (PROS)지속적 투여 및 장기 안전성을 위한 알펠리시브(BYL719) 후속 연구
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
리드: 노바티스
- 2상모집 예정· Multiple Sclerosis (MS) - Relapsing-remittingA Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS
협력: 노바티스
- 2상모집 중· Anatomic Stage IV Breast Cancer AJCC v8177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
협력: 노바티스
- 2상모집 중· Primary Immune Thrombocytopenia (ITP)A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
리드: 노바티스
- 2상모집 중· Primary Immune ThrombocytopeniaStudy of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab
리드: 노바티스
- 2상모집 예정· Localized Cutaneous LeishmaniasisA Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
협력: 노바티스
- 2상모집 중· Liver Cancer68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
협력: 노바티스
- 2상모집 예정· Cancer of Unknown PrimaryPhase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
협력: 노바티스
- 2상초청 등록· Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaAdding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
협력: 노바티스
- 2상모집 중· Hypertension (HTN)An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
리드: 노바티스
- 2상모집 중· Chronic Myelogenous LeukemiaStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
리드: 노바티스
- 2상모집 예정· Chronic Myeloid Leukemia (CML) inASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic Myelogenous Leukemia in Chronic Phase (ASC2ADVANCE)
협력: 노바티스
- 2상모집 예정· Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML
협력: 노바티스
- 2상모집 중· Immunoglobulin A Nephropathy (IgAN)A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
리드: 노바티스
- 2상모집 중· Geographic Atrophy Secondary to Age-related Macular DegenerationA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
리드: 노바티스
- 2상모집 중· Non-segmental VitiligoA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
리드: 노바티스
- 2상모집 중· Oligometastatic Prostate AdenocarcinomaAlpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
협력: 노바티스
- 2상모집 중· CryptosporidiosisStudy Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
리드: 노바티스
- 2상모집 중단 (진행 중)· Lipoprotein DisorderA Study of DII235 in Adults With Elevated Lipoprotein(a)
리드: 노바티스
- 2상모집 중단 (진행 중)· Atopic DermatitisPhase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
리드: 노바티스
- 2상모집 중· PIK3CA-related Overgrowth Spectrum (PROS)EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
리드: 노바티스
- 2상모집 중단 (진행 중)· Metastatic Castration Resistant Prostate Cancer (mCRPC)An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC
리드: 노바티스
- 2상모집 중단 (진행 중)· Ras/MAPK Pathway Vascular Anomalies24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
협력: 노바티스
- 2상모집 중· Alzheimer's DiseaseA Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
리드: 노바티스
- 2상모집 중· HER2 Negative Breast CancerImpact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
협력: 노바티스
- 2상모집 중· Metastatic Hormone-sensitive Prostate CancerAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
리드: 노바티스
- 2상모집 중단 (진행 중)· Prostatic Cancer, Castration-ResistantA Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
리드: 노바티스
- 2상모집 중· Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
리드: 노바티스
- 2상모집 중· Metastatic Castration-Resistant Prostate CarcinomaLow PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
협력: 노바티스
- 2상모집 중· Chagas DiseaseA Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
리드: 노바티스
- 2상모집 중단 (진행 중)· HypertensionA Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
리드: 노바티스
- 2상모집 중· ANCA Associated Vasculitis (AAV)Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
리드: 노바티스
- 2상모집 중· Prostate AdenocarcinomaNeoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
협력: 노바티스
- 2상모집 중· Glomerulonephritis, IGAStudy to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
리드: 노바티스
- 2상모집 중· Chronic Myeloid Leukemia (CML)Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.
리드: 노바티스
- 2상모집 중· Malignant Solid TumorsPhase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
협력: 노바티스
- 2상모집 중단 (진행 중)· Idiopathic Inflammatory MyopathiesPhase 2 Study of Rapcabtagene Autoleucel in Myositis
리드: 노바티스
- 2상모집 중· Scleroderma, DiffusePhase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
리드: 노바티스
- 2상모집 중단 (진행 중)· Amyotrophic Lateral Sclerosis (ALS)A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
리드: 노바티스
- 2상모집 중· Diffuse Cutaneous Systemic SclerosisA Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
리드: 노바티스
- 2상모집 중· Castration-Resistant Prostate CarcinomaVorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
협력: 노바티스
- 2상모집 중단 (진행 중)· Endometroid Endometrial CancerA Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
협력: 노바티스
- 2상모집 중· Lupus Erythematosus, SystemicA Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
리드: 노바티스
- 2상모집 중· High Grade GliomaStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
협력: 노바티스
- 2상모집 중단 (진행 중)· Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated VasculitisIptacopan in Patients With ANCA Associated Vasculitis
리드: 노바티스
- 2상모집 중· Castration-Resistant Prostate CarcinomaRe-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.